© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
Health System
FDA Issues EUA for First Point-of-Care COVID-19 Antibody Test
September 24, 2020
The Assure test is the only FDA authorized COVID-19 point-of-care serology test.
Over the Counter: The "Disruptors" and the Role of Innovation in Drug Pricing
September 17, 2020
Eric Levin, CEO of Scripta Insights, discusses how "positive disruption" from private companies are positioned to confront challenges within the pharmaceutical industry.
Boston Medical Center Reduces Opioid Use in Surgical Patients
September 17, 2020
Pharmacists, nurses, and physicians work together to combat the overuse of powerful pain relievers.
Baricitinib Plus Remdesivir Improves Recovery Time for Hospitalized COVID-19
September 15, 2020
Early data from a phase 3 trial showed that baricitinib combined with remdesivir improved recovery in patients hospitalized with COVID-19 compared with remdesivir alone.
Coronavirus News Roundup: Pharmacists Authorized to Administer COVID-19 Vaccines, MJH Life Sciences to Host Webinar on Dual Flu, COVID-19 Threats
September 11, 2020
Here's this week's coronavirus-related news you should know.
FDA Alert: Efficacy Concerns with Atezolizumab Plus Paclitaxel for Breast Cancer
September 11, 2020
The FDA issued a safety alert about efficacy and potential safety concerns with a combination therapy being studied for the treatment of breast cancer.
Oncology Pharmacists Adapt to Serve Patients Amid Pandemic
September 10, 2020
Oncology pharmacists have implemented new ways to communicate with patients, schedule visits and treatments, and re-evaluate their medications regimens during the pandemic.
Coronavirus News Roundup: FDA Issues EUA for Rapid Antigen Test, ASHP Releases COVID-19 Vaccine Guidelines
August 28, 2020
Here's the coronavirus-related news from this week that you should know.
ASHP Outlines Tenets for COVID-19 Vaccine Rollout and Oversight
August 27, 2020
ASHP issued its recommended principles for the development, distribution, allocation, and oversight of an eventual COVID-19 vaccine.
FDA Removes Boxed Warning for Amputation Risk From Canagliflozin
August 27, 2020
The removal of the boxed warning from canagliflozin was based on the FDA’s review of new data from 3 clinical trials.